Skip to main content
OpenTrials

Clinical trial condition

Resectable Pancreatic Adenocarcinoma

Explore clinical trials studying Resectable Pancreatic Adenocarcinoma. Study availability and eligibility vary by location and protocol.

11 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Resectable Pancreatic Adenocarcinoma trial results

Recruiting

APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

NCT04858334

Conditions
Pancreatic Acinar Cell Carcinoma, Pancreatic Adenosquamous Carcinoma, Pancreatic Squamous Cell Carcinoma, +4 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 454 locations
View Trial Details
Recruiting

Neoadjuvant Triple Therapy for (Borderline) Resectable Pancreatic Cancer (PREOPANC-5)

NCT06384560

Conditions
Borderline Resectable Pancreatic Adenocarcinoma, Localized Pancreatic Adenocarcinoma, Resectable Pancreatic Adenocarcinoma
Locations
  • Amsterdam University Medical Center Amsterdam, Netherlands
  • Maastricht University Medical Center Maastricht, Netherlands
  • St. Antonius Ziekenhuis Nieuwegein, Netherlands
  • Erasmus University Medical Center Rotterdam, Netherlands
View Trial Details
Recruiting

Perioperative NALIRIFOX (liposomal Irinotecan in Combination with Fluorouracil, Leucovorin, and Oxaliplatin) in Resectable Pancreatic Adenocarcinoma: Randomized Phase II Trial

NCT06816914

Conditions
Resectable Pancreatic Adenocarcinoma
Locations
  • Kaohsiung Chang Gung Memorial Hospital Kaohsiung City, Taiwan
  • Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Taiwan
  • China Medical University Hospital Taichung, Taiwan
  • Taichung Veterans General Hospital Taichung, Taiwan
View Trial Details
Active, Not Recruiting

Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer

NCT04927780

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
Locations
  • Jeroen Bosch Hospital 's-Hertogenbosch, Netherlands
  • Meander Medical Center Amersfoort, Netherlands
  • Amsterdam UMC Amsterdam, Netherlands
  • OLVG Amsterdam, Netherlands
View all 21 locations
View Trial Details

Related conditions